{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:42:50Z","timestamp":1787164970404,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971653"],"award-info":[{"award-number":["81971653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572319"],"award-info":[{"award-number":["82572319"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M762244"],"award-info":[{"award-number":["2024M762244"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025HXBH087"],"award-info":[{"award-number":["2025HXBH087"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2024-YF05-00632-SN"],"award-info":[{"award-number":["2024-YF05-00632-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00259-026-07838-x","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:23:14Z","timestamp":1774250594000},"page":"5060-5073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A deep learning PET\/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study"],"prefix":"10.1007","volume":"53","author":[{"given":"Hexiao","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zekun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-9004","authenticated-orcid":false,"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"7838_CR1","doi-asserted-by":"crossref","unstructured":"Luminari SJEJOO. High-risk follicular lymphoma patients: identification and treatment. 2018;23(1):19\u201329.","DOI":"10.1016\/S1470-2045(18)30688-0"},{"key":"7838_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/hon.2437_85","volume":"35","author":"S Huet","year":"2017","unstructured":"Huet S, Szafer-Glusman E, Xerri L, Bolen C, Punnoose E, Tonon L, et al. Evaluation of clinicogenetic risk models for outcome of follicular lymphoma patients in the PRIMA trial. Hematol Oncol. 2017;35:96\u20137.","journal-title":"Hematol Oncol"},{"issue":"suppl 2","key":"7838_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/hon.2438_91","volume":"35","author":"S Luminari","year":"2017","unstructured":"Luminari S, Marcheselli L, Manni M, Anastasia A, Vitolo U, Chiarenza A, et al. POD24 and CR30 are promising surrogate endpoints for assessing the outcome of patients with advanced stage follicular lymphoma enrolled in the FOLL05 trial by FIL. Hematol Oncol. 2017;35(suppl 2):228\u20139.","journal-title":"Hematol Oncol"},{"issue":"16_suppl","key":"7838_CR4","doi-asserted-by":"publisher","first-page":"7524","DOI":"10.1200\/JCO.2023.41.16_suppl.7524","volume":"41","author":"R Nair","year":"2023","unstructured":"Nair R, Jacobs R, Cho S-G, Devata S, Gaballa S, Yoon DH, et al. High complete response rate with TNB-486 in relapsed\/refractory follicular lymphoma: interim results from an ongoing phase 1 study. J Clin Oncol. 2023;41(16_suppl):7524\u20137524.","journal-title":"J Clin Oncol"},{"issue":"23","key":"7838_CR5","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","volume":"33","author":"C Casulo","year":"2015","unstructured":"Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the National LymphoCare Study. J Clin Oncol. 2015;33(23):2516\u201322.","journal-title":"J Clin Oncol"},{"key":"7838_CR6","unstructured":"Casulo C, Le-Rademacher J, Dixon J, Salles G, Hoster E, Herold M, Hiddemann W, Sebban C, Marcus R, Kimby EJB. Validation of POD24 as a robust early clinical endpoint of poor survival in follicular lymphoma: results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) investigation using individual data from 5,453 patients on 13 clinical trials. Blood. 2017;130:412."},{"issue":"6","key":"7838_CR7","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3324\/haematol.2018.209015","volume":"104","author":"JF Seymour","year":"2019","unstructured":"Seymour JF, Marcus R, Davies A, Gallop-Evans E, Grigg A, Haynes A, et al. Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression. Haematologica. 2019;104(6):1202\u20138.","journal-title":"Haematologica"},{"issue":"5","key":"7838_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"5","key":"7838_CR9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104(5):1258\u201365.","journal-title":"Blood"},{"issue":"27","key":"7838_CR10","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555\u201362.","journal-title":"J Clin Oncol"},{"issue":"1","key":"7838_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood-2017-11-816405","volume":"132","author":"E Bachy","year":"2018","unstructured":"Bachy E, Maurer MJ, Habermann TM, Gelas-Dore B, Maucort-Boulch D, Estell JA, et al. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy. Blood. 2018;132(1):49\u201358.","journal-title":"Blood"},{"issue":"1","key":"7838_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1182\/hematology.2024000662","volume":"2024","author":"P Mondello","year":"2024","unstructured":"Mondello P, Casulo C. The pod24 challenge: where do we go from here for early progressors? Hematol Am Soc Hematol Educ Program. 2024;2024(1):301\u20139.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"1","key":"7838_CR13","doi-asserted-by":"publisher","first-page":"W91","DOI":"10.2214\/AJR.09.2637","volume":"194","author":"CG Cronin","year":"2010","unstructured":"Cronin CG, Swords R, Truong MT, Viswanathan C, Rohren E, Giles FJ, et al. Clinical utility of PET\/CT in lymphoma. AJR Am J Roentgenol. 2010;194(1):W91-103.","journal-title":"AJR Am J Roentgenol"},{"issue":"1042","key":"7838_CR14","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140360","volume":"87","author":"U Metser","year":"2014","unstructured":"Metser U, Hussey D, Murphy G. Impact of (18)F-FDG PET\/CT on the staging and management of follicular lymphoma. Br J Radiol. 2014;87(1042):20140360.","journal-title":"Br J Radiol"},{"issue":"1127","key":"7838_CR15","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20210448","volume":"94","author":"M Meignan","year":"2021","unstructured":"Meignan M, Cottereau AS, Specht L, Mikhaeel NG. Total tumor burden in lymphoma - an evolving strong prognostic parameter. Br J Radiol. 2021;94(1127):20210448.","journal-title":"Br J Radiol"},{"issue":"1","key":"7838_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3324\/haematol.2020.263194","volume":"107","author":"C Rossi","year":"2022","unstructured":"Rossi C, Tosolini M, Gravelle P, Pericart S, Kanoun S, Evrard S, et al. Baseline SUVmax is related to tumor cell proliferation and patient outcome in follicular lymphoma. Haematologica. 2022;107(1):221\u201330.","journal-title":"Haematologica"},{"issue":"3","key":"7838_CR17","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.21037\/qims-24-1504","volume":"15","author":"Q Jiang","year":"2025","unstructured":"Jiang Q, Lin Z, Chen Q, Lin F, Jiang C, Deng M, et al. Integration of PET\/CT parameters and a clinical variable to predict the risk of progression of disease within 24 months (POD24) in follicular lymphoma. Quant Imaging Med Surg. 2025;15(3):2468\u201380.","journal-title":"Quant Imaging Med Surg"},{"issue":"3","key":"7838_CR18","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10967-024-09359-z","volume":"333","author":"S Das","year":"2024","unstructured":"Das S, Gupta R, Das J, Ray S. Role of 18F-FDG PET\/CT for predicting bone marrow involvement, disease relapse and histopathological transformation in follicular lymphoma\u2014a single centre observation. J Radioanal Nucl Chem. 2024;333(3):1627\u201332.","journal-title":"J Radioanal Nucl Chem"},{"issue":"Supplement 1","key":"7838_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1182\/blood-2024-209642","volume":"144","author":"A Sarrabay","year":"2024","unstructured":"Sarrabay A, Baaklini S, Barthelemy C, Gil L, Beyou A, Dahbi L, Mossadegh-Keller N, Huber C, Navarro J-M, Salles G, et al. A Single Cell Atlas of Follicular Lymphoma across Clinical Stages Defines Tumor B Cell Archetypes, Immune Microenvironment Heterogeneity and Novel Cell States Associated with High-Risk FL. Blood. 2024;144(Supplement 1):740\u2013740.","journal-title":"Blood"},{"issue":"4","key":"7838_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.26599\/BDMA.2024.9020058","volume":"7","author":"Z Jiang","year":"2024","unstructured":"Jiang Z, Cheng D, Qin Z, Gao J, Lao Q, Bakhrom Ismoilovich A, et al. TV-SAM: Increasing Zero-Shot Segmentation Performance on Multimodal Medical Images Using GPT-4 Generated Descriptive Prompts Without Human Annotation. Big Data Mining and Analytics. 2024;7(4):1199\u2013211.","journal-title":"Big Data Mining and Analytics"},{"issue":"1","key":"7838_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44824-z","volume":"15","author":"J Ma","year":"2024","unstructured":"Ma J, He Y, Li F, Han L, You C, Wang B. Segment anything in medical images. Nat Commun. 2024;15(1):654.","journal-title":"Nat Commun"},{"issue":"2","key":"7838_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/med4.21","volume":"1","author":"H Ali","year":"2023","unstructured":"Ali H. Generative pre-trained transformer 4 in healthcare: challenges, opportunities, and recommendations. Medicine Advances. 2023;1(2):163\u20136.","journal-title":"Medicine Advances"},{"key":"7838_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7091301","volume":"2023","author":"B Sistaninejhad","year":"2023","unstructured":"Sistaninejhad B, Rasi H, Nayeri P. A review paper about deep learning for medical image analysis. Comput Math Methods Med. 2023;2023:7091301.","journal-title":"Comput Math Methods Med"},{"key":"7838_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-bioeng-071516-044442","volume":"19","author":"D Shen","year":"2017","unstructured":"Shen D, Wu G, Suk HI. Deep Learning in Medical Image Analysis. Annu Rev Biomed Eng. 2017;19:221\u201348.","journal-title":"Annu Rev Biomed Eng"},{"issue":"7","key":"7838_CR25","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1007\/s00259-025-07090-9","volume":"52","author":"C Jiang","year":"2025","unstructured":"Jiang C, Jiang Z, Zhang Z, et al. An explainable transformer model integrating PET and tabular data for histologic grading and prognosis of follicular lymphoma: a multi-institutional digital biopsy study. Eur J Nucl Med Mol Imaging. 2025;52(7):2384\u201396.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"7838_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-025-03893-7","volume":"23","author":"C Jiang","year":"2025","unstructured":"Jiang C, Qian C, Jiang Q, et al. Virtual biopsy for non-invasive identification of follicular lymphoma histologic transformation using radiomics-based imaging biomarker from PET\/CT. BMC Med. 2025;23(1):49.","journal-title":"BMC Med"},{"issue":"4","key":"7838_CR27","volume":"13","author":"DC Popescu","year":"2025","unstructured":"Popescu DC, G\u0103man MA. Artificial intelligence for risk stratification in diffuse large B-cell lymphoma: a systematic review of classification models and predictive performances. Med Sci (Basel). 2025;13(4):280.","journal-title":"Med Sci (Basel)"},{"issue":"16","key":"7838_CR28","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche C, Orlhac F, Boughdad S, Reuz\u00e9 S, Goya-Outi J, Robert C, et al. LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78(16):4786\u20139.","journal-title":"Cancer Res"},{"issue":"3","key":"7838_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2967\/jnumed.121.262117","volume":"63","author":"JJ de Eertink","year":"2022","unstructured":"Eertink JJ, Pfaehler EA, Wiegers SE, Lugtenburg PJ, Hoekstra OS, Zijlstra JM, de Vet HC. Boellaard RJJoNM: Quantitative radiomics features in diffuse large B-cell lymphoma: does segmentation method matter? J Nucl Med. 2022;63(3):389\u201395.","journal-title":"J Nucl Med"},{"key":"7838_CR30","unstructured":"Mueller A, Siems J, Nori H, Salinas D, Zela A, Caruana R, Hutter F. GAMformer: in-context learning for generalized additive models. arXiv preprint arXiv: 2410.04560v1. 2024."},{"key":"7838_CR31","unstructured":"Mueller A, Siems J, Nori H, Salinas D, Zela A, Caruana R, Hutter F. GAMformer: Bridging tabular foundation models and interpretable machine learning. arXiv preprint arXiv:2410.04560IF: NA NA NA, 2024."},{"key":"7838_CR32","unstructured":"M\u00fcller A, Curino C, Ramakrishnan R. MotherNet: A foundational hypernetwork for tabular classification. arXiv preprint arXiv:2312.08598IF: NA NA NA, 2023."},{"issue":"8045","key":"7838_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41586-024-08328-6","volume":"637","author":"N Hollmann","year":"2025","unstructured":"Hollmann N, M\u00fcller S, Purucker L, Krishnakumar A, K\u00f6rfer M, Hoo SB, Schirrmeister RT, Hutter F. Accurate predictions on small data with a tabular foundation model. Nature. 2025;637(8045):319\u201326.","journal-title":"Nature"},{"key":"7838_CR34","unstructured":"Zeng Y, Dinh T, Kang W. Mueller ACJapa: Tabflex: Scaling tabular learning to millions with linear attention. 2025."},{"key":"7838_CR35","unstructured":"Breugel BV, Schaar MVD. Position: why tabular foundation models should be a research priority. In: Proceedings of the 41st International Conference on Machine Learning. vol. 235. Vienna, Austria: JMLR.org; 2024: Article 2003."},{"key":"7838_CR36","doi-asserted-by":"crossref","unstructured":"Jiang Z, Jia R, Zhang L, Li K. Pre-Trained Tabular Transformer for Real-Time, Efficient, Stable Radiomics Data Processing: A Comprehensive Study. In: 2023 IEEE International Conference on E-health Networking, Application & Services (Healthcom): 15\u201317 Dec. 2023;276\u2013281.","DOI":"10.1109\/Healthcom56612.2023.10472397"},{"issue":"1","key":"7838_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00716-4","volume":"13","author":"J Zha","year":"2025","unstructured":"Zha J, Chen Q, Zhang W, Jing H, Ye J, Liu H, et al. A machine learning-based model to predict POD24 in follicular lymphoma: a study by the Chinese workshop on follicular lymphoma. Biomark Res. 2025;13(1):2.","journal-title":"Biomark Res"},{"key":"7838_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943151","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Wang M, Zhang Y, Hu F, Wang K, Wang C, et al. Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET\/CT. Front Oncol. 2022;12:943151.","journal-title":"Front Oncol"},{"key":"7838_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1200\/JCO-25-00892","volume":"44","author":"MJ Maurer","year":"2026","unstructured":"Maurer MJ, Prochazka VK, El-Galaly TC, Flowers CR, Villa D, Bachy E, et al. FLIPI24: a modern prognostic model and clinical trial enrichment tool for newly diagnosed follicular lymphoma. J Clin Oncol. 2026;44:117\u201328.","journal-title":"J Clin Oncol"},{"key":"7838_CR40","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1007\/s12325-021-01738-2","volume":"38","author":"E Bachy","year":"2021","unstructured":"Bachy E, Rufibach K, Parreira J, Launonen A, Nielsen T, Hackshaw A. Phase III clinical trials in first-line follicular lymphoma: a review of their design and interpretation. Adv Ther. 2021;38:3489\u2013505.","journal-title":"Adv Ther"},{"key":"7838_CR41","doi-asserted-by":"publisher","first-page":"e919","DOI":"10.1097\/HS9.0000000000000919","volume":"7","author":"W Townsend","year":"2023","unstructured":"Townsend W, Hiddemann W, Buske C, Cartron G, Cunningham D, Dyer MJS, et al. Obinutuzumab versus rituximab immunochemotherapy in previously untreated iNHL: final results from the GALLIUM study. HemaSphere. 2023;7:e919.","journal-title":"HemaSphere"},{"issue":"1","key":"7838_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-023-00462-z","volume":"11","author":"J Zha","year":"2023","unstructured":"Zha J, Chen Q, Ye J, Yu H, Yi S, Zheng Z, et al. Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1\u20132 follicular lymphoma: a real-world multicenter study. Biomark Res. 2023;11(1):16.","journal-title":"Biomark Res"},{"key":"7838_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1090610","volume":"13","author":"J Hu","year":"2023","unstructured":"Hu J, Gao F, Zhao J, Song W, Wang Y, Zheng Y, et al. The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma. Front Oncol. 2023;13:1090610.","journal-title":"Front Oncol"},{"key":"7838_CR44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1470-2045(18)30102-5","volume":"19","author":"S Huet","year":"2018","unstructured":"Huet S, Tesson B, Jais JP, Feldman AL, Magnano L, Thomas E, et al. A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts. Lancet Oncol. 2018;19:549\u201361.","journal-title":"Lancet Oncol"},{"key":"7838_CR45","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","volume":"128","author":"V Jurinovic","year":"2016","unstructured":"Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, et al. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood. 2016;128:1112\u201320.","journal-title":"Blood"},{"key":"7838_CR46","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/ajh.25973","volume":"95","author":"F Mir","year":"2020","unstructured":"Mir F, Mattiello F, Grigg A, Herold M, Hiddemann W, Marcus R, et al. Follicular lymphoma evaluation index (FLEX): a new clinical prognostic model that is superior to existing risk scores for predicting progression-free survival and early treatment failure after frontline immunochemotherapy. Am J Hematol. 2020;95:1503\u201310.","journal-title":"Am J Hematol"},{"issue":"1","key":"7838_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/med4.70000","volume":"3","author":"H Yuan","year":"2025","unstructured":"Yuan H. Agentic large language models for healthcare: current progress and future opportunities. Med Adv. 2025;3(1):37\u201341.","journal-title":"Med Adv"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-026-07838-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-026-07838-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T09:23:02Z","timestamp":1780996982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-026-07838-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["7838"],"URL":"https:\/\/doi.org\/10.1007\/s00259-026-07838-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the institutional review board of West China Hospital, Sichuan University (IRB No. 2024\u20131010).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For the nature of retrospective study, written informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}